TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis

Y Hao, D Baker, P Ten Dijke - International journal of molecular sciences, 2019 - mdpi.com
Transforming growth factor β (TGF-β) is a secreted cytokine that regulates cell proliferation,
migration, and the differentiation of a plethora of different cell types. Consistent with these …

[HTML][HTML] The role of tumor-stroma interactions in drug resistance within tumor microenvironment

Y Ni, X Zhou, J Yang, H Shi, H Li, X Zhao… - Frontiers in Cell and …, 2021 - frontiersin.org
Cancer cells resistance to various therapies remains to be a key challenge nowadays. For a
long time, scientists focused on tumor cells themselves for the mechanisms of acquired drug …

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer

S Chen, P Xie, M Cowan, H Huang… - The Journal of …, 2022 - Am Soc Clin Investig
Background Immune checkpoint inhibitors (ICIs) have modest activity in ovarian cancer
(OC). To augment their activity, we used priming with the hypomethylating agent …

Aspects of the epigenetic regulation of EMT related to cancer metastasis

E Nowak, I Bednarek - Cells, 2021 - mdpi.com
Epithelial to mesenchymal transition (EMT) occurs during the pathological process
associated with tumor progression and is considered to influence and promote the …

PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma

A Asgarova, K Asgarov, Y Godet, P Peixoto… - …, 2018 - Taylor & Francis
Tumor cells, which undergo Epithelial-mesenchymal transition (EMT) acquire increased
capacities of proliferation, invasion and have the ability to generate metastases by escaping …

Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer

RA Sample, MF Nogueira, RD Mitra, SV Puram - Oncogene, 2023 - nature.com
Epithelial-to-mesenchymal transition (EMT) is a process by which cells lose their epithelial
characteristics and gain mesenchymal phenotypes. In cancer, EMT is thought to drive tumor …

Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer

M Desbois, AR Udyavar, L Ryner, C Kozlowski… - Nature …, 2020 - nature.com
Close proximity between cytotoxic T lymphocytes and tumour cells is required for effective
immunotherapy. However, what controls the spatial distribution of T cells in the tumour …

Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

J Argemi, MU Latasa, SR Atkinson, IO Blokhin… - Nature …, 2019 - nature.com
Alcoholic hepatitis (AH) is a life-threatening condition characterized by profound
hepatocellular dysfunction for which targeted treatments are urgently needed. Identification …

[HTML][HTML] Nucleosidic DNA demethylating epigenetic drugs–a comprehensive review from discovery to clinic

K Agrawal, V Das, P Vyas, M Hajdúch - Pharmacology & therapeutics, 2018 - Elsevier
DNA methylation plays a pivotal role in the etiology of cancer by mediating epigenetic
silencing of cancer-related genes. Since the relationship between aberrant DNA methylation …

[HTML][HTML] The potential role of nitric oxide in halting cancer progression through chemoprevention

H Vahora, MA Khan, U Alalami… - Journal of cancer …, 2016 - ncbi.nlm.nih.gov
Nitric oxide (NO) in general plays a beneficial physiological role as a vasorelaxant and the
role of NO is decided by its concentration present in physiological environments. NO either …